Don’t miss essential insights from this three-part webinar series.

Alexa Berk is the Chief Scientific Officer for Real World Evidence at CVS Clinical Trial services. Alexa has worked in health research for nearly 20 years, including health outcomes research design and management positions at Memorial Sloan-Kettering Cancer Center and at top pharmaceutical and medical device companies, managing large-scale global clinical trials. Most recently she was the Medical Affairs Director for Digital Health and Data at Invitae, a leading medical genetics company. She has co-authored several journal articles in research literature including publications in the Journal of Clinical Oncology, Radiology, and the Journal of Cancer Education. She is a frequent panelist on topics around high-quality, patient-centric, and equitable real-world evidence, and has presented her research at annual conferences for the American Psychological Association, the Society of Behavioral Medicine, the International Society for Pharmacoeconomics and Outcomes Research, the Miami Breast Cancer Conference, and the American Psychosocial Oncology Society. Alexa has also taught undergraduate- and graduate-level classes at the New School for Social Research and the Columbia University School of Social Work, with a focus on health disparities, patient-reported outcomes, and research ethics in vulnerable populations.

Andrew C. von Eschenbach, M.D. currently serves as President of Samaritan Health Initiatives, Inc. and as an Adjunct Professor at University of Texas MD Anderson Cancer Center. From September of 2005 to January 2009 he served as Commissioner of Food and Drugs where he championed an agenda to modernize the FDA by process improvement of the regulatory pathway for drugs and medical devices and by fostering creative projects, including FDA’s Critical Path Initiative (designed to bring modern tools of science to the product development process); work plans like the FDA’s Food Protection Plan; and most especially the nurturing of the workforce through initiatives, such as an Agency-wide fellowship program and development of a new integrated campus for the Agency in White Oak, Maryland. Under his leadership, the FDA experienced dramatic increases in resources enabling implementation of many new programs designed to strengthen the FDA in its mission to protect and promote public health. He has emphasized FDA’s role in working with external partners to assure quality throughout the entire life cycle of the products it regulates.

Jill Pellegrino is Vice President of Recruitment and Real World Evidence (RWE), CVS Health Clinical Trial Services. She and her team are responsible for leading the Recruitment and RWE product suite for pharmaceutical manufacturers. Jill has 15 years’ experience in clinical research with expertise in recruitment, study conduct, real world evidence and data analytics. Previously she worked at Accelerated Enrollment Solutions where she served as General Manager. Her responsibilities included overseeing the company's patient recruitment business as well as 160 clinical research sites across 11 countries.

Henriette Coetzer, M.D., serves as the Chief Medical Officer for Recruitment and RWE, CVS Clinical Trial Services. A critical care physician by training, Henriette has practiced medicine on virtually every continent and has worked in the U.S. and the European Union to redesign systems and pathways of care using RWE to maximize value and efficiency and to engage policy-makers, providers and patients. At the start of the Covid pandemic she returned to frontline practice delivering critical care to Covid patients and eventually overseeing and redesigning systems to ensure patient safety in a rapidly changing delivery environment. At Health Dialog in Boston, Henriette worked with Dartmouth’s Institute of Health Policy on RWE frameworks to illuminate and understand variation in real-world practice. As Chief Clinical Risk Officer at Rowdmap she worked on the use of the Centers for Medicare and Medicaid Services (CMS) datasets to identify providers, their case mix and natural groupings that produce consistently superior value and outcomes. In the United Kingdom, she served as the Director for Clinical Transformation for the National Health Service building a new care delivery model for the optimal care of the elderly. She started consulting with CVS Health in 2017 on evidence-based program designs before joining Clinical Trial Services in 2019.

Christopher P. Boone, PhD is an accomplished global executive, strategist, social scientist, and data technologist with a passion for reinventing and transforming healthcare and life sciences companies utilizing enterprise data & analytics capabilities to drive value creation. Chris has a career-long history as a dynamic, innovative thought leader and a public voice on the power of real-world evidence, health informatics, and enterprise data & analytics, and its ability to radically transform the global health care system into a learning health care system. Currently, Chris serves as the Vice President, Global Head of Health Economics and Outcomes Research at AbbVie. He is also an adjunct assistant professor of health administration at the New York University's Robert F. Wagner Graduate School of Public Service, an active board member of several influential organizations, and a co-founder of a few start-up companies. Prior to AbbVie, he served in two different roles at Pfizer: (1) the Vice President and Head of Global Medical Epidemiology and Big Data Analysis, and (2) the Vice President and Global Head of Real-World Data and Analytics. Chris has been recognized as a Top Diverse Leaders by the Illinois Diversity and Leadership Council (2021), a Global Top 100 Innovator in Data & Analytics (2020, 2019), an Emerging Pharma Leader by Pharmaceutical Executive (2018), and a Top 40 Under 40 Leaders in Health (2017) by the National Minority Quality Forum (NMQF).